Melanoma in situ of right eyelid, including canthus
ICD-10 D03.11 is a billable code used to indicate a diagnosis of melanoma in situ of right eyelid, including canthus.
Melanoma in situ of the right eyelid, including the canthus, is a localized form of skin cancer characterized by the presence of atypical melanocytes confined to the epidermis. This condition is considered a precursor to invasive melanoma and is typically asymptomatic in its early stages. Clinically, it may present as a pigmented lesion or a non-pigmented area that may be mistaken for other skin conditions. The eyelid, being a delicate area, requires careful monitoring and management due to the potential for cosmetic and functional impairment. Diagnosis is usually confirmed through a biopsy, which reveals atypical melanocytes without invasion into the dermis. Surveillance protocols for patients diagnosed with melanoma in situ include regular dermatological examinations and patient education on self-monitoring for changes in skin lesions. The risk of progression to invasive melanoma is present, particularly if the lesion is not adequately treated, making early intervention crucial.
Detailed descriptions of the lesion, biopsy results, and treatment plans.
Diagnosis and management of melanoma in situ, follow-up care, and patient education.
Ensure accurate documentation of lesion characteristics and treatment response.
Documentation of ocular examination findings and any impact on vision.
Management of eyelid lesions and potential surgical interventions.
Coordination with dermatology for comprehensive care.
Used when excising a melanoma in situ from the right eyelid.
Document the size of the lesion, excision margins, and pathology results.
Ensure coordination between dermatology and ophthalmology for eyelid lesions.
Coding melanoma in situ accurately is crucial for tracking disease progression, guiding treatment decisions, and ensuring appropriate follow-up care to prevent invasive melanoma.
